Key takeaways
- “KLOW” is a seller name for a vial listing GHK-Cu, BPC-157, TB-500 and KPV, not a single defined molecule.
- Check that the COA names the same batch as the vial and reports results for each listed peptide separately.
- An identity result and a purity result answer different questions; neither alone establishes the amount of every component.
- A COA documents results for the sample tested, not every vial or every possible quality property.
01What a report for a four-peptide vial should show
There is no single COA layout used by every laboratory. The general checks for any report, and the order to run them in, are on how to read a COA; the rows below show what each field has to show for a vial that lists four peptides.
| Field | What to check on a COA for a vial listing four peptides |
|---|---|
| Material name and form | The document names the tested material and identifies the chemical form where relevant. A name alone does not tell you that four separate components were tested. |
| Components tested | Look for a separate line for GHK-Cu, BPC-157, TB-500 and KPV. The document should make clear which result belongs to which component. |
| Batch or lot number | Compare the number on the document with the number printed on the vial. If they differ, the document does not match that vial’s stated batch. |
| Sample and test dates | Look for dates tied to the sample and laboratory work. A date by itself does not show which batch was tested. |
| Laboratory identity | Check that the laboratory is named and that the report identifies who authorized or reviewed it. |
| Test method | Each result should name its method. “Identity” or “purity” without a method leaves you unable to tell what the reported number represents. |
| Identity result | Check for an identity result for each listed peptide, with the expected reference and observed result where the method reports them. |
| Purity and amount results | Look for separate results for each component, and check whether the document distinguishes purity from measured peptide content. One total for the vial cannot show the split between its components. |
For active pharmaceutical ingredients covered by FDA’s Q7A guidance, a certificate should identify the material and batch, list tests and acceptance limits with results, and be dated and signed. That guidance is not a universal template for every research-material document.
02What identity and purity results mean
Identity asks whether the sample’s analytical result is consistent with the named component. Mass spectrometry (MS) can report a measured mass for comparison with an expected value. The comparison only makes sense when the expected value matches the chemical form named on the document.
| Listed component | Expected mass information in FDA’s 2026 briefings | What the COA should show |
|---|---|---|
| BPC-157 | Free base: 1419.5 g/mol | A separate identity result for BPC-157, with the relevant expected and observed values. |
| TB-500 | Free base: 889.01 g/mol | A separate identity result. Check that the chemical form stated on the COA matches the mass reference. |
| KPV | Free base: 342.43 g/mol | A separate identity result for KPV, not a result attributed to the mixture as a whole. |
| GHK-Cu | This page does not give a numeric reference mass. | Look for a separate identity result that identifies GHK-Cu and its method. |
These FDA values are for the named free-base forms; they are reference information, not test results for a KLOW vial. In one 2024 nomination FDA reviewed for another peptide, the certificate named the acetate salt while the nomination named the free base, and the certificate gave the free base’s formula and weight. That is why the form and identity result need to be read together.
Purity is also not the same as amount. A percentage labelled “purity” reports a result from the stated method; it does not, by itself, give the measured mass of each peptide in a mixed vial. In the same 2024 review, FDA described a supplier’s certificate that reports purity and peptide content as separate results. Read the labels on the results rather than treating one percentage as both.
03Match the report to the vial
Matching the lot is a document check, not evidence that every possible property was tested.
Find the batch or lot identifier on the vial label. Do not substitute a product name for the lot number.
Check the COA’s material name and lot field. If the identifiers do not match, the report does not document the batch named on the vial.
Look for four component-specific identity results and four component-specific amount results, rather than one result for an undivided mixture.
Confirm that each test names a method and that the document identifies when the analysis was performed and who reviewed or authorized it.
FDA’s Q7A guidance says that laboratory records identify the sample and batch, methods, data, results, acceptance criteria, and test and review dates or signatures. It also describes batch numbers as identifiers that can connect material to its production and distribution history. Those are useful checks on traceability; a matching number alone does not confirm a document’s authenticity.
For the broader checks that apply to any report, read how to read a COA.
04What a COA cannot tell you
A COA reports results from tests on a sample. It does not automatically show that every listed component was tested, that a reported percentage is the amount in the vial, or that the sample represents every vial associated with the batch. Read the named tests and results, not a general “pass” statement on its own.
One result
A single identity result does not establish the identities of four separately listed peptides.
One percentage
A total or purity percentage for a mixture cannot show the separate amount of each component.
One matching number
A matching lot number helps link the document and vial, but does not independently verify the test data or every quality property.
This page shows no result from any batch. A page about how to inspect the document does not establish what any particular vial contains.